Volume 9, Number 6—June 2003
Research
Histopathologic Features of Mycobacterium ulcerans Infection
Jeannette Guarner*
, Jeanine Bartlett*, Ellen A. Spotts Whitney*, Pratima L. Raghunathan*, Ymkje Stienstra†, Kwame Asamoa‡, Samuel Etuaful§, Erasmus Klutse¶, Eric Quarshie#, Tjip S. van der Werf†, Winette T.A. van der Graaf†, C. Harold King**, and David A. Ashford*
, Jeanine Bartlett*, Ellen A. Spotts Whitney*, Pratima L. Raghunathan*, Ymkje Stienstra†, Kwame Asamoa‡, Samuel Etuaful§, Erasmus Klutse¶, Eric Quarshie#, Tjip S. van der Werf†, Winette T.A. van der Graaf†, C. Harold King**, and David A. Ashford*
Table 2
Number (percent) of specimens with other diagnoses, definite, and suspected Buruli ulcer according to clinical stagea
| Clinical stage | Other diagnoses | Definite BU (AFB positive) | Suspect BU (AFB negative) | Total |
|---|---|---|---|---|
| Nodule |
7 (6) |
18 (14) |
5 (4) |
30 (24) |
| Plaque |
0 |
5 (4) |
1 (0.8) |
6 (5) |
| Ulcer |
2 (1.6) |
55 (44) |
31 (25) |
88 (71) |
| Total | 9 (7) | 78 (63) | 37 (30) | 124 (100) |
aBU, Buruli ulcer; AFB, acid-fast bacilli.
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.